Fundamental dimension Equity attribute | BYDPeer $71.69▼-0.80% Cap $5.21BP/E 10.8x QuantScore54/100 | ALSNPeer $106.32▼-2.97% Cap $8.78BP/E 16.8x QuantScore42/100 | CHDNLeader $83.73▼-0.85% Cap $5.84BP/E 14.3x QuantScore60/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
61/100 |
23/100 |
73/100 |
Valuation Multiples, PEG & DCF upside | 75/100 | 76/100 | 96/100 |
Health Piotroski, Altman Z, leverage & liquidity | 28/100 | 26/100 | 21/100 |
Growth Revenue / earnings growth & margins | 31/100 | 30/100 | 26/100 |
Sentiment Analyst ratings, targets & revisions | 74/100 | 53/100 | 83/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 10.8x | 16.8x | 14.3x |
Forward P/E (next FY) | 10.0x | 13.1x | 12.3x |
EV / EBITDA (TTM) | 7.4x | 11.4x | 9.3x |
Price / Sales | 1.3x | 2.4x | 2.0x |
Price / Free Cash Flow | 148.5x | 12.0x | 15.3x |
PEG ratio | -0.15 | -0.58 | -28.05 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 6 / 9 | 5 / 9 | 8 / 9 |
Altman Z-Score | 2.22 (Grey) | 1.70 (Distress) | 1.47 (Distress) |
Total debt / equity | 1.30 | 2.08 | 3.57 |
Quick ratio | 0.7x | 1.2x | 0.3x |
Interest coverage | 7.2x | 5.6x | 2.5x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +4.1% | -6.7% | +7.0% |
Net income growth YoY | +218.9% | -14.8% | -11.0% |
Gross margin (TTM) | 30.0% | 39.5% | 37.2% |
Operating margin (FY) | 21.4% | 32.3% | 25.2% |
FCF margin (FY) | 9.5% | 21.6% | 10.6% |
5. Trailing price performancePrice change over period |
1M return | -0.2% | -5.7% | +5.4% |
3M return | -17.6% | -13.1% | -3.2% |
6M return | -14.5% | -21.5% | -17.5% |
Year to date | -15.9% | +8.6% | -26.4% |
1Y return | -9.0% | +28.4% | -17.1% |
3Y return | +17.5% | +85.1% | -24.9% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $411.75 +474.3% upside | $83.46 -21.5% premium | $158.42 +89.2% upside |
Wall Street consensus target | $87.70 +22.3% · range $80.00–$103.00 | $127.00 +19.5% · range $120.00–$135.00 | $131.67 +57.3% · range $119.00–$145.00 |
Consensus stance | 64% Buy36% Hold0% Sell | 28% Buy52% Hold21% Sell | 100% Buy0% Hold0% Sell |